Researchers have shown that Receptor for Advanced Glycation End Products (RAGE) helps to regulate a key signaling pathway known to promote both acute and chronic inflammation. The development of ...
Triple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease that represents about 15% of breast cancer cases. Classified as mesenchymal tumors, this subgroup of TNBC present the ...
RAGE plays key role in cellular mechanisms of plasticity in aggressive triple-negative breast cancer
Breast cancer is the most frequent cancer among women, affecting 2 million women worldwide each year. TNBC represents about 15% of all breast cancer cases and is a particularly aggressive form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback